{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:47:06Z","timestamp":1790880426787,"version":"4.1.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.dld.2019.09.016","type":"journal-article","created":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T00:14:48Z","timestamp":1571444088000},"page":"1621-1632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9503-8639","authenticated-orcid":false,"given":"Edith","family":"Lahner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9949-8619","authenticated-orcid":false,"given":"Rocco Maurizio","family":"Zagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-8645","authenticated-orcid":false,"given":"Antonio","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Meggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Vincenzo","family":"Lenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9120-5957","authenticated-orcid":false,"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino Roberto","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.09.016_bib0005","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2002.01301.x","article-title":"Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading","volume":"16","author":"Rugge","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bpg.2014.10.005","article-title":"Chronic gastritis \u2014 an update","volume":"28","author":"Varbanova","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrgastro.2013.101","article-title":"Autoimmune atrophic gastritis\u2014pathogenesis, pathology and management","volume":"10","author":"Neumann","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0020","first-page":"301","article-title":"The biological model of gastric carcinogenesis","volume":"157","author":"Correa","year":"2004","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.dld.2019.09.016_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000335595","article-title":"ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms","volume":"95","author":"Delle Fave","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dld.2019.09.016_bib0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF01071995","article-title":"A reappraisal of the nature and significance of chronic atrophic gastritis","volume":"18","author":"Strickland","year":"1973","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis: the updated Sydney system","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2019.09.016_bib0040","first-page":"4737","article-title":"Gastric precancerous process in a high risk population: cohort follow-up","volume":"50","author":"Correa","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2019.09.016_bib0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00365529109104000","article-title":"Chronic gastritis: progession of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects","volume":"26","author":"Villako","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0050","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(95)91084-0","article-title":"Long-term sequelae of Helicobacter pylori gastritis","volume":"345","author":"Kuipers","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2019.09.016_bib0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.dld.2010.10.012","article-title":"Reversal of atrophic body gastritis after H. Pylori eradication at long-term follow-up","volume":"43","author":"Vannella","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0060","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1046\/j.1365-2036.2002.01311.x","article-title":"Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis","volume":"16","author":"Ito","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-134-5-200103060-00010","article-title":"Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated","volume":"134","author":"Ohkusa","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0070","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1572-0241.1998.00454.x","article-title":"Reversal of fundic atrophy after eradication of Helicobacter pylori","volume":"93","author":"Tucci","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2019.09.016_bib0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1523-5378.2007.00563.x","article-title":"The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis","volume":"12","author":"Rokkas","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/gast.2001.21187","article-title":"H[+],K[+]-atpase [proton pump] is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis","volume":"120","author":"D\u2019Elios","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.016_bib0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1568-9972(02)00066-6","article-title":"Immunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis","volume":"1","author":"van Driel","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2019.09.016_bib0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0167-5699(00)01653-4","article-title":"The causative H+\/K+ ATPase antigen in the pathogenesis of autoimmune gastritis","volume":"21","author":"Toh","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.dld.2019.09.016_bib0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.advms.2015.12.004","article-title":"Anti-parietal cell antibodies - diagnostic significance","volume":"61","author":"Rusak","year":"2016","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.dld.2019.09.016_bib0100","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood-2005-09-3534","article-title":"Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion","volume":"107","author":"Hershko","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.dld.2019.09.016_bib0105","first-page":"766","article-title":"High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study","volume":"94","author":"Marignani","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cgh.2012.02.018","article-title":"Common features of patients with autoimmune atrophic gastritis","volume":"10","author":"Miceli","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0115","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/MEG.0000000000001246","article-title":"Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms","volume":"30","author":"Lahner","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/apt.15317","article-title":"Determinants of diagnostic delay in autoimmune atrophic gastritis","volume":"50","author":"Lenti","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2019.09.016_bib0130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1158\/1055-9965.EPI-05-0931","article-title":"Prevalence of chronic atrophic gastritis in different parts of the world","volume":"15","author":"Weck","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2019.09.016_bib0135","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/00365520310007224","article-title":"Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection","volume":"38","author":"Sipponen","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0140","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1440-1746.2010.06608.x","article-title":"Helicobacter pylori infection and gastritis: the systematic investigation of gastrointestinal diseases in China [SILC]","volume":"26","author":"Zou","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.ejcn.1602059","article-title":"Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders","volume":"59","author":"Green","year":"2005","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.dld.2019.09.016_bib0150","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2036.2007.03430.x","article-title":"Epidemiology of chronic atrophic gastritis: populationbased study among 9444 older adults from Germany","volume":"26","author":"Weck","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10654-010-9482-0","article-title":"Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies","volume":"25","author":"Adamu","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.dld.2019.09.016_bib0160","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/00365521.2010.487918","article-title":"Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints","volume":"45","author":"Telaranta-Keerie","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0165","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1080\/00365520802273025","article-title":"Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study","volume":"43","author":"Storskrubb","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0170","first-page":"4129","article-title":"Prevalence of H. pylori infection and atrophic gastritis in a population-based screening with serum biomarker panel [GastroPanel\u00ae] in St. Petersburg","volume":"36","author":"Roman","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.dld.2019.09.016_bib0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MEG.0000000000000065","article-title":"Prevalence of gastric precancerous conditions: a systematic review and meta-analysis","volume":"26","author":"Marques-Silva","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0180","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/gut.2007.127167","article-title":"Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands","volume":"56","author":"de Vries","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0185","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.cgh.2015.04.001","article-title":"Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in Northern Sweden between 1990 and 2009","volume":"13","author":"Song","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000338295","article-title":"Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis","volume":"86","author":"Soykan","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2019.09.016_bib0195","doi-asserted-by":"crossref","first-page":"e5784","DOI":"10.1097\/MD.0000000000005784","article-title":"Upper gastrointestinal symptoms in autoimmune gastritis: a crosssectional study","volume":"96","author":"Carabotti","year":"2017","journal-title":"Medicine [Baltimore]"},{"key":"10.1016\/j.dld.2019.09.016_bib0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/nmo.12723","article-title":"Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring","volume":"28","author":"Tenca","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2019.09.016_bib0205","first-page":"1","article-title":"Gastroesophageal reflux symptoms and microscopic esophagitis in a cohort of consecutive patients affected by atrophic body gastritis: a pilot study","volume":"13","author":"Carabotti","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/08916930410001705439","article-title":"Pernicious anemia","volume":"37","author":"Toh","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2019.09.016_bib0215","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.3748\/wjg.15.5121","article-title":"Pernicious anemia: new insights from a gastroenterological point of view","volume":"15","author":"Lahner","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0220","first-page":"585","article-title":"Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia","volume":"90","author":"Hershko","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.dld.2019.09.016_bib0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(01)00883-X","article-title":"Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms","volume":"111","author":"Annibale","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3748\/wjg.v23.i4.563","article-title":"Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: a review","volume":"23","author":"Cavalcoli","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0235","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.hoc.2016.03.001","article-title":"Neurologic manifestations of blood dyscrasias","volume":"30","author":"Couriel","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.dld.2019.09.016_bib0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/appi.neuropsych.11020052","article-title":"The neuropsychiatry of vitamin B12 deficiency in elderly patients","volume":"24","author":"Lachner","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.dld.2019.09.016_bib0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.33590\/emjgastroenterol\/10314623","article-title":"Atrophic body gastritis: clinical presentation, diagnosis, and outcome","volume":"6","author":"Lahner","year":"2017","journal-title":"EMJ Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0250","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v24.i12.1343","article-title":"Correlation between serum vitamin B12 level and peripheral neuropathy in atrophic gastritis","volume":"24","author":"Yang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0255","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/NDT.S72491","article-title":"Iron deficiency and cognitive functions","volume":"10","author":"J\u00e1uregui-Lobera","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.dld.2019.09.016_bib0260","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.dld.2018.08.028","article-title":"Deficiency of micronutrients in patients affected by chronic atrophic autoimmune gastritis: a single-institution observational study","volume":"51","author":"Zilli","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2036.2003.01820.x","article-title":"Atrophic gastritis as a cause of hyperhomocysteinaemia","volume":"19","author":"Santarelli","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0270","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13256-017-1415-z","article-title":"Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia: a case series","volume":"11","author":"Ammouri","year":"2017","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.dld.2019.09.016_bib0275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1752-1947-8-286","article-title":"Portal, superior mesenteric and splenic vein thrombosis secondary to hyperhomocysteinemia with pernicious anemia: a case report","volume":"8","author":"Venkatesh","year":"2014","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.dld.2019.09.016_bib0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.medcli.2010.01.011","article-title":"Portal and mesenteric vein thrombosis associated with hyperhomocysteinemia and pernicious anemia in a patient heterozygous for the MTHFR C677T mutation","volume":"136","author":"Fern\u00e1ndez-Ruiz","year":"2011","journal-title":"Med Clin [Barc]"},{"key":"10.1016\/j.dld.2019.09.016_bib0285","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1157\/13079763","article-title":"Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia","volume":"205","author":"Fern\u00e1ndez-Miranda","year":"2005","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.dld.2019.09.016_bib0290","first-page":"88","article-title":"Clinical manifestations of chronic atrophic gastritis","volume":"89","author":"Rodriguez-Castro","year":"2018","journal-title":"Acta Biomed"},{"key":"10.1016\/j.dld.2019.09.016_bib0295","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.atherosclerosis.2011.11.029","article-title":"Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study","volume":"220","author":"Sch\u00f6ttker","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dld.2019.09.016_bib0300","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2016.03.025","article-title":"Polyautoimmunity in autoimmune gastritis","volume":"31","author":"Kalkan","year":"2016","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0305","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2007.09.025","article-title":"Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis","volume":"121","author":"Lahner","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2018.11.009","article-title":"Bringing complexity into clinical practice: an internistic approach","volume":"61","author":"Corazza","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0315","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0016-5085(91)90023-E","article-title":"Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa","volume":"101","author":"Negrini","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.016_bib0320","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/gast.1996.v111.pm8780570","article-title":"Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis","volume":"111","author":"Negrini","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.016_bib0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/gast.2001.21187","article-title":"H(+),K(+)-atpase [proton pump] is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis","volume":"120","author":"D\u2019Elios","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.016_bib0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08830180590884611","article-title":"Molecular specificity and functional properties of autoreactive T cell response in human gastric autoimmunity","volume":"24","author":"D\u2019Elios","year":"2005","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.dld.2019.09.016_bib0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.1995.tb00079.x","article-title":"Association of Helicobacter pylori and gastric autoimmunity: a population-based study","volume":"11","author":"Uibo","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.dld.2019.09.016_bib0340","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0016-5085(91)90199-U","article-title":"Helicobacter pylori infection in pernicious anemia: a prospective controlled study","volume":"100","author":"Fong","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.016_bib0345","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1523-5378.2003.00187.x","article-title":"Helicobacter pylori infection and gastric autoimmune diseases: is there a link?","volume":"8","author":"Presotto","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1523-5378.2007.00467.x","article-title":"CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis","volume":"12","author":"Annibale","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0355","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S1590-8658(00)80351-5","article-title":"Role of Helicobacter pylori infection in pernicious anaemia","volume":"32","author":"Annibale","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/oxfordjournals.epirev.a036078","article-title":"The epidemiology of Helicobacter pylori infection","volume":"13","author":"Taylor","year":"1991","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.dld.2019.09.016_bib0365","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.dld.2017.06.010","article-title":"Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases","volume":"49","author":"Di Sabatino","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0370","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.autrev.2010.08.006","article-title":"Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases","volume":"10","author":"Tozzoli","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2019.09.016_bib0375","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1038\/ctg.2016.71","article-title":"Luminescent immunoprecipitation system [LIPS] for detection of autoantibodies against ATP4A and ATP4B subunits of gastric proton pump H+,K+-ATPase in atrophic body gastritis patients","volume":"8","author":"Lahner","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0380","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/ajg.2009.231","article-title":"Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency","volume":"104","author":"Lahner","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0385","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.dld.2010.04.011","article-title":"HLA-DRB1*03 and DRB1*04 are associated with atrophic gastritis in an Italian population","volume":"42","author":"Lahner","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0390","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/apt.12177","article-title":"Systematic review: gastric cancer incidence in pernicious anaemia","volume":"37","author":"Vannella","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0395","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2019.09.016_bib0400","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2018.08.011","article-title":"The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective","volume":"18","author":"Massironi","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2019.09.016_bib0405","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1001\/archinte.159.15.1726","article-title":"Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association","volume":"159","author":"Centanni","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0410","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fendo.2017.00092","article-title":"Hashimoto\u2019s thyroiditis and autoimmune gastritis","volume":"8","author":"Cellini","year":"2017","journal-title":"Front Endocrinol [Lausanne]"},{"key":"10.1016\/j.dld.2019.09.016_bib0415","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2007-2134","article-title":"Autoimmune gastritis in type 1 diabetes: a clinically oriented review","volume":"93","author":"De Block","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.dld.2019.09.016_bib0420","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40618-017-0755-2","article-title":"Anti-parietal cell antibodies in patients with autoimmune thyroid diseases","volume":"41","author":"Utiyama","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.dld.2019.09.016_bib0425","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2019.09.016_bib0430","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/diacare.26.1.82","article-title":"Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings","volume":"26","author":"De Block","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2019.09.016_bib0435","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.13115","article-title":"A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study","volume":"192","author":"Kozhakhmetova","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2019.09.016_bib0440","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.autrev.2013.07.006","article-title":"Autoimmune polyendocrine syndromes","volume":"13","author":"Cutolo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2019.09.016_bib0445","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/120347541201600408","article-title":"Vitiligo and associated autoimmune disease: retrospective review of 300 patients","volume":"16","author":"Sawicki","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.dld.2019.09.016_bib0450","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-010-9312-x","article-title":"Screening for associated autoimmune disorders in Polish patients with Addison\u2019s disease","volume":"37","author":"Fichna","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.dld.2019.09.016_bib0455","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(00)70410-0","article-title":"Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori","volume":"118","author":"El-Omar","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.016_bib0460","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.10637","article-title":"Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients","volume":"101","author":"Chang","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2019.09.016_bib0465","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000151297","article-title":"Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil","volume":"78","author":"Motta","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2019.09.016_bib0470","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/gut.50.6.779","article-title":"Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study","volume":"50","author":"The Eurohepygast Study Group","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15430\/JCP.2013.18.2.149","article-title":"Risk factors of atrophic gastritis and intestinal metaplasia in first-degree relatives of gastric cancer patients compared with age-sex matched controls","volume":"18","author":"Oh","year":"2013","journal-title":"J Cancer Prev"},{"key":"10.1016\/j.dld.2019.09.016_bib0480","first-page":"2567","article-title":"Gastric mucosa alterations in first-degree relatives of gastric cancer patients","volume":"25","author":"Romiti","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.dld.2019.09.016_bib0485","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00008469-199305000-00008","article-title":"Characteristics of the gastric mucosa of direct relatives of patients with sporadic gastric carcinoma","volume":"2","author":"Carneiro","year":"1993","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.dld.2019.09.016_bib0490","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/MEG.0b013e3283398d37","article-title":"Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis","volume":"22","author":"Rokkas","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0495","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/ije\/dyx238","article-title":"Family history of gastric mucosal abnormality and the risk of gastric cancer: a population-based observational study","volume":"47","author":"Song","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.dld.2019.09.016_bib0500","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/2050640616642341","article-title":"Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection","volume":"5","author":"Nishizawa","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2019.09.016_bib0505","first-page":"1401","article-title":"Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for longterm safety","volume":"90","author":"Kuipers","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0510","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0515","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1046\/j.1365-2036.2001.01105.x","article-title":"Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa","volume":"15","author":"Geboes","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0520","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2005.086579","article-title":"Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK","volume":"55","author":"Garc\u00eda Rodr\u00edguez","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0525","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/sjg.SJG_573_16","article-title":"Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: a meta-analysis","volume":"23","author":"Li","year":"2017","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0530","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection \u2014 the maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0535","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0540","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/00365521.2011.645501","article-title":"Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers","volume":"47","author":"Agr\u00e9us","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0545","first-page":"1","article-title":"Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.09.016_bib0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12393","article-title":"Detection of gastric atrophy by circulating pepsinogens: a comparison of three assays","volume":"22","author":"Leja","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0555","first-page":"1","article-title":"The diagnostic value of gastrin-17 detection in atrophic gastritis. A meta-analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2019.09.016_bib0560","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jclinpath-2015-203405","article-title":"Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis","volume":"69","author":"Venerito","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2019.09.016_bib0565","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.14248","article-title":"Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis","volume":"46","author":"Zagari","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0570","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.28470","article-title":"Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogens and Helicobacter pylori antibody titer","volume":"134","author":"Yoshida","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2019.09.016_bib0575","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1038\/ctg.2016.42","article-title":"Pepsinogens to distinguish patients with gastric intestinal metaplasia and Helicobacter pylori infection among populations at risk for gastric cancer","volume":"7","author":"De Re","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0580","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00365521.2015.1083049","article-title":"Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference","volume":"51","author":"Eun Bae","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0585","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/gutjnl-2014-308536","article-title":"Detection of precancerous gastric lesions and gastric cancer through exhaled breath","volume":"65","author":"Amal","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0590","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.autrev.2015.08.004","article-title":"New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract","volume":"14","author":"Di Sabatino","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2019.09.016_bib0595","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1746.1991.tb01468.x","article-title":"The sydney system: histological division","volume":"6","author":"Price","year":"1991","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0600","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3748\/wjg.v19.i10.1523","article-title":"Intestinal metaplasia surveillance: searching for the roadmap","volume":"19","author":"Zullo","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0605","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.dld.2008.02.030","article-title":"OLGA staging for gastritis: a tutorial","volume":"40","author":"Rugge","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0610","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1523-5378.2010.00760.x","article-title":"Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions","volume":"15","author":"de Vries","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0615","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.dld.2008.02.027","article-title":"The impact of biopsy number and site on the accuracy of intestinal metaplasia detection in the stomach. A morphometric study based on virtual biopsies","volume":"40","author":"Mastracci","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0620","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","article-title":"The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis","volume":"71","author":"Capelle","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2019.09.016_bib0625","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/gutjnl-2017-314600","article-title":"Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients","volume":"68","author":"Rugge","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0630","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gut.52.8.1111","article-title":"The long term outcome of gastric non-invasive neoplasia","volume":"52","author":"Rugge","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0635","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0031-1291537","article-title":"A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions","volume":"44","author":"Pimentel-Nunes","year":"2012","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2019.09.016_bib0640","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0031-1291491","volume":"44","author":"Dinis-Ribeiro","year":"2012","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2019.09.016_bib0645","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3109\/00365521.2013.825315","article-title":"Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies","volume":"48","author":"Kikuste","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0650","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000487470","article-title":"Narrow-band imaging: clinical application in gastrointestinal endoscopy","volume":"26","author":"Barbeiro","year":"2018","journal-title":"GE Port J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0655","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0042-108435","article-title":"A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions","volume":"48","author":"Pimentel-Nunes","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2019.09.016_bib0660","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/a-0808-3186","article-title":"Endoscopic grading of gastric intestinal metaplasia [EGGIM]: a multicenter validation study","volume":"51","author":"Esposito","year":"2019","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2019.09.016_bib0665","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the OLGA staging system","volume":"56","author":"Rugge","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0670","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1365-2036.2010.04277.x","article-title":"Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study","volume":"31","author":"Rugge","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0675","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41395-018-0353-8","article-title":"OLGA Gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients","volume":"113","author":"Rugge","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0680","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gutjnl-2017-314498","article-title":"Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions","volume":"68","author":"den Hollander","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0685","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10120-018-0812-3","article-title":"The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis","volume":"21","author":"Yue","year":"2018","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.dld.2019.09.016_bib0690","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/hel.12149","article-title":"Detection of gastric precancerous conditions in daily clinical practice: a nationwide survey","volume":"19","author":"Lahner","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0695","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/794378","article-title":"Gastric carcinogenesis and underlying molecular mechanisms: Helicobacter pylori and novel targeted therapy","volume":"2015","author":"Nishizawa","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.dld.2019.09.016_bib0700","first-page":"177","article-title":"Schistosomes, liver flukes and Helicobacter pylori: infection with Helicobacter pylori. Monographs on the evaluation of carcinogenic risks to humans","volume":"61","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"1994","journal-title":"Int Agency Res Cancer"},{"key":"10.1016\/j.dld.2019.09.016_bib0705","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199110173251604","article-title":"Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii","volume":"325","author":"Nomura","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0710","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.016_bib0715","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.302.6788.1302","article-title":"Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation","volume":"302","author":"Forman","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2019.09.016_bib0720","first-page":"414","article-title":"A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer","volume":"30","author":"Rokkas","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0725","first-page":"S37","article-title":"Helicobacter pylori and gastric carcinogenesis","volume":"19","author":"Correa","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"Suppl","key":"10.1016\/j.dld.2019.09.016_bib0730","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/00365529109103982","article-title":"Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results long-term follow-up three family samples","volume":"186","author":"Ihamaki","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0735","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/gut.32.10.1110","article-title":"Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up","volume":"32","author":"Rokkas","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.016_bib0740","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process \u2014 first American Cancer society award lecture on cancer epidemiology and prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2019.09.016_bib0745","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.54.9.679","article-title":"Gastric intestinal metaplasia: subtypes and natural history","volume":"54","author":"El-Zimaity","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2019.09.016_bib0750","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0016-5085(97)70076-3","article-title":"Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study","volume":"113","author":"Van Der Hulst","year":"1997","journal-title":"Gastroenterology"},{"issue":"October (5)","key":"10.1016\/j.dld.2019.09.016_bib0755","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1083-4389.2004.00262.x","article-title":"Role of noninvasive tests [C-urea breath test and stool antigen test] as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis","volume":"9","author":"Lahner","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0760","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bpg.2012.12.007","article-title":"Precancerous lesions in the stomach: from biology to clinical patient management","volume":"27","author":"Rugge","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0765","first-page":"3967","article-title":"Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk western population","volume":"351","author":"Song","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2019.09.016_bib0770","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/hel.12150","article-title":"Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions","volume":"19","author":"Areia","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2019.09.016_bib0775","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.dld.2016.12.004","article-title":"Cost of detecting neoplasia by surveillance endoscopy in atrophic gastritis in Italy: a low risk country","volume":"49","author":"Lahner","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.016_bib0780","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2008.01.071","article-title":"Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands","volume":"134","author":"De Vries","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.016_bib0785","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/apt.12515","article-title":"Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems","volume":"38","author":"Cho","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0790","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/00365521.2015.1010570","article-title":"Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up","volume":"50","author":"Lahner","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0795","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/apt.12177","article-title":"Systematic review: gastric cancer incidence in pernicious anaemia","volume":"37","author":"Vannella","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0800","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/jgh.13313","article-title":"Meta-analysis. The diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesions","volume":"31","author":"Zhao","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.016_bib0805","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.3748\/wjg.v11.i34.5351","article-title":"Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis","volume":"11","author":"Annibale","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0810","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1038\/nrdp.2017.40","article-title":"Vitamin B12 deficiency","volume":"3","author":"Green","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.dld.2019.09.016_bib0815","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/humu.22970","article-title":"Mutation update and review of severe methylenetetrahydrofolate reductase deficiency","volume":"37","author":"Froese","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.dld.2019.09.016_bib0820","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.15254","article-title":"Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders","volume":"182","author":"Bergamaschi","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.dld.2019.09.016_bib0825","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2013-10-512624","article-title":"How I treat unexplained refractory iron deficiency anemia","volume":"123","author":"Hershko","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.dld.2019.09.016_bib0830","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/apt.15191","article-title":"Review article: treatment options for functional dyspepsia","volume":"49","author":"Masuy","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0835","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818805597","article-title":"Insights into the evaluation and management of dyspepsia: recent developments and new guidelines","volume":"11","author":"Black","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0840","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2036.2003.01669.x","article-title":"The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis","volume":"18","author":"Kamada","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.016_bib0845","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000486618","article-title":"Helicobacter pylori eradication therapy ameliorates latent digestive symptoms in chronic atrophic gastritis","volume":"97","author":"Yamada","year":"2018","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2019.09.016_bib0850","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3748\/wjg.v24.i22.2373","article-title":"Treatment of Helicobacter pylori infection in atrophic gastritis","volume":"24","author":"Lahner","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.016_bib0855","article-title":"Long-term proton pump inhibitor [PPI] use and the development of gastric pre-malignant lesions","volume":"12","author":"Song","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819308369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819308369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:09:52Z","timestamp":1761624592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819308369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":171,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1590865819308369"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.09.016","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}